Sus Clinicals, Inc. – Trademark Portfolio
Entity Type: 03
Sus Clinicals, Inc. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include ONCOPIG, SUS CLINICALS, and ONCOPIG CANCER MODEL. The owner is based in Cincinnati, OH.
9100 Indian Ridge Lane
Cincinnati, OH 45243
Showing of trademarks Trademarks
Trademark Classifications
Sus Clinicals, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Raw and unprocessed agricultural, aquacultural, horticultural and forestry products
Frequently Asked Questions
How many trademarks does Sus Clinicals, Inc. have?
Sus Clinicals, Inc. has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.
What trademark classes does Sus Clinicals, Inc. file in?
Sus Clinicals, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 1 (Chemicals), Class 31 (Natural Agricultural Products). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Sus Clinicals, Inc.'s most well-known trademarks?
Sus Clinicals, Inc.'s registered trademark portfolio includes well-known marks such as ONCOPIG, SUS CLINICALS, and ONCOPIG CANCER MODEL. These are among 3 currently registered trademarks in the portfolio.
What is Sus Clinicals, Inc.'s trademark registration success rate?
Sus Clinicals, Inc. has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.